About This Event
Join us and our panels of experts for a thought-provoking exploration on investing in oncology.
100% of proceeds from ticket sales and sponsorships will directly support the Damon Runyon Cancer Research Foundation and the Parker Institute for Cancer Immunotherapy.
The Damon Runyon Cancer Research Foundation funds high-risk, high-reward cancer research. For over 75 years, promising young scientists identified and supported by Damon Runyon have gone on to make breakthrough discoveries that have transformed our understanding of cancer and develop new approaches to prevention, diagnosis, and treatment of all forms of this disease. Thirteen Damon Runyon scientists have received the Nobel Prize.
The Parker Institute for Cancer Immunotherapy is redefining how cancer research moves from discovery to impact. We unite top scientists at leading institutions—including Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Pennsylvania, Dana-Farber Cancer Institute, Gladstone Institutes, and Weill Cornell Medicine—to accelerate the development of breakthrough immune therapies. By funding bold ideas, dismantling barriers to collaboration, and driving promising discoveries forward, we ensure that the most transformative treatments reach patients faster. Our mission: turn all cancers into curable diseases.
About This Event
Join us and our panels of experts for a thought-provoking exploration on investing in oncology.
100% of proceeds from ticket sales and sponsorships will directly support the Damon Runyon Cancer Research Foundation and the Parker Institute for Cancer Immunotherapy.
The Damon Runyon Cancer Research Foundation funds high-risk, high-reward cancer research. For over 75 years, promising young scientists identified and supported by Damon Runyon have gone on to make breakthrough discoveries that have transformed our understanding of cancer and develop new approaches to prevention, diagnosis, and treatment of all forms of this disease. Thirteen Damon Runyon scientists have received the Nobel Prize.
The Parker Institute for Cancer Immunotherapy is redefining how cancer research moves from discovery to impact. We unite top scientists at leading institutions—including Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Pennsylvania, Dana-Farber Cancer Institute, Gladstone Institutes, and Weill Cornell Medicine—to accelerate the development of breakthrough immune therapies. By funding bold ideas, dismantling barriers to collaboration, and driving promising discoveries forward, we ensure that the most transformative treatments reach patients faster. Our mission: turn all cancers into curable diseases.